The motion to resume debate is a dilatory motion that is not debatable, so we will go straight to a vote.
Just for clarity, the motion that Dr. Ellis moved at the last meeting, which is the subject of the motion to resume, reads as follows:
That the Institute for Safe Medication Practices Canada provide the list of 700 incident adverse reactions, the date of incident, product and outcome to the standing committee on health within 30 days.
The question for the committee is, shall the debate on that motion resume?